Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

Novo Nordisk has launched a direct-to-consumer (DTC) option for uninsured or under-insured people wanting to access its GLP-1 ...

Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Republicans trying to find billions of Medicaid dollars to pay for tax cuts now say that any reduction in Medicaid spending ...

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating for individuals affected by obesity. This year's theme, "Commit to Care," emphasizes ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...